Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene transfer into hematopoietic cells: progress, problems and prospects

M S Dilber1

  • 1Department of Hematology and Medicine, Huddinge Hospital, Karolinska Institute, Sweden.

The Turkish Journal of Pediatrics
|October 9, 1998
PubMed
Summary

Gene therapy using hematopoietic stem cells (HSC) shows promise for treating diseases by correcting genetic defects. However, challenges remain in achieving efficient gene transfer and expression in humans compared to animal models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prognostic significance of 8p21 deletion in multiple myeloma.

British journal of haematology·2008
Same author

OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h.

Gene therapy·2007
Same author

Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.

Cancer gene therapy·2006
Same author

Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice.

Leukemia·2006
Same author

Genetically modified autoactivated cells expressing intracellular forms of GM-CSF as a model for regulated administration of cytokines.

Scandinavian journal of immunology·2005
Same author

Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.

Leukemia·2003

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Hematology

Background:

  • Gene therapy introduces genetic material into somatic cells for therapeutic purposes.
  • Hematopoietic stem cells (HSC) are prime candidates for gene modification due to their regenerative potential.
  • Over 250 gene transfer protocols involve hematopoietic cell manipulation.

Purpose of the Study:

  • To explore the potential of gene therapy targeting HSC for treating congenital and acquired diseases.
  • To investigate the efficiency and challenges of gene transfer into HSC for clinical applications.

Main Methods:

  • Utilizing retroviral vectors for in vitro transduction of hematopoietic progenitor cells and long-term culture-initiating cells (LTC-IC).
  • Evaluating gene expression and transduction efficiency in mouse models post-transplantation.

Related Experiment Videos

  • Comparing results from animal models with primate models and human clinical trials.

    • Main Results:

    • High transduction efficiency and long-term expression were achieved in mice after HSC gene manipulation.
    • Similar success has not been consistently observed in primate models or human trials, with reasons yet to be fully understood.
    • Major hurdles in cancer gene therapy include transduction rate, selectivity, and effectiveness due to tumor heterogeneity.

    Conclusions:

    • Despite challenges, gene therapy holds significant promise for future clinical applications.
    • Further advancements in cell biology, immunology, and delivery systems are crucial for overcoming current limitations.
    • Hematopoietic stem cell-based gene therapy remains an encouraging avenue for treating a range of diseases.